SSA
MNOV icon

Schonfeld Strategic Advisors’s MediciNova MNOV Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.8K Buy
36,376
+329
+0.9% +$498 ﹤0.01% 1963
2025
Q4 		$47.2K Buy
36,047
+1,397
+4% +$1.93K ﹤0.01% 1883
2025
Q3 		$44K Sell
34,650
-100
-0.3% -$129 ﹤0.01% 2072
2025
Q2 		$45.5K Sell
34,750
-388
-1% -$543 ﹤0.01% 1891
2025
Q1 		$51.3K Sell
35,138
-613
-2% -$1.08K ﹤0.01% 2069
2024
Q4 		$75.1K Sell
35,751
-5,349
-13% -$10.4K ﹤0.01% 1857
2024
Q3 		$86.3K Sell
41,100
-600
-1% -$888 ﹤0.01% 1875
2024
Q2 		$60K Sell
41,700
-500
-1% -$700 ﹤0.01% 1918
2024
Q1 		$61.2K Buy
42,200
+600
+1% +$852 ﹤0.01% 1890
2023
Q4 		$62.4K Sell
41,600
-600
-1% -$1.08K ﹤0.01% 1654
2023
Q3 		$88.2K Sell
42,200
-100
-0.2% -$233 ﹤0.01% 1506
2023
Q2 		$97.3K Sell
42,300
-1,000
-2% -$2.2K ﹤0.01% 1729
2023
Q1 		$93.5K Sell
43,300
-1,200
-3% -$2.75K ﹤0.01% 1704
2022
Q4 		$91.2K Sell
44,500
-900
-2% -$1.99K ﹤0.01% 2200
2022
Q3 		$99K Buy
45,400
+100
+0.2% +$231 ﹤0.01% 2560
2022
Q2 		$115K Sell
45,300
-5,100
-10% -$13.3K ﹤0.01% 2095
2022
Q1 		$135K Buy
50,400
+5,800
+13% +$14.2K ﹤0.01% 2140
2021
Q4 		$119K Buy
+44,600
New +$149K ﹤0.01% 1853

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Schonfeld Strategic Advisors's MNOV Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its MediciNova (MNOV) stake by 0.91% in Q1 2026, buying an estimated $498 and bringing the position to 36,376 shares worth $49.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1963.

Schonfeld Strategic Advisors first reported a position in MNOV in Q4 2021 and has held it in 18 quarters since. The position peaked at $135K in Q1 2022. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

  • Schonfeld Strategic Advisors held 36,376 shares of MediciNova worth $49.8K as of Q1 2026.
  • Schonfeld Strategic Advisors bought 329 MediciNova shares in Q1 2026, an estimated $498.
  • MediciNova made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1963 holding.
  • Schonfeld Strategic Advisors first reported a position in MediciNova in Q4 2021 and has held it in 18 quarters since.
  • Schonfeld Strategic Advisors's MediciNova position peaked at $135K in Q1 2022.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.